dr. vaishampayan on axitinib plus pembrolizumab in advanced rcc
Published 4 years ago • 905 plays • Length 1:17Download video MP4
Download video MP3
Similar videos
-
2:31
axitinib plus pembrolizumab in advanced rcc
-
1:56
dr. cost on pembrolizumab plus axitinib in patients with rcc
-
1:40
dr. powles on fda approval of pembrolizumab plus axitinib in advanced rcc
-
1:00
dr. vaishampayan on the potential of tivozanib in advanced rcc
-
3:30
promising results for axitinib and pembrolizumab in advanced renal cell cancer
-
1:00
pembrolizumab/axitinib and avelumab/axitinib combo for rcc
-
1:34
dr. rini on pembrolizumab plus axitinib in rcc
-
1:04
dr. rini discusses pembrolizumab plus axitinib in mrcc
-
2:32
avelumab plus axitinib improves survival in advanced renal-cell carcinoma patients
-
5:10
real-world treatment outcomes of 1l axitinib pembrolizumab in patients with advanced rcc in the us
-
0:54
dr. vaishampayan on immunotherapy in mrcc
-
1:03
dr. rini on managing the toxicity of pembrolizumab plus axitinib in mrcc
-
2:18
pembrolizumab monotherapy and pembro-axitinib for rcc
-
2:02
dr. mcgregor on implications of the fda approval of pembrolizumab/axitinib in rcc
-
1:28
dr. vaishampayan on the role of cytoreductive nephrectomy in mrcc
-
1:06
exciting potential of pembrolizumab combined with axitinib for kidney cancer
-
1:45
keynote-426: pembrolizumab and axitinib vs sunitinib in advanced renal cell carcinoma
-
1:16
dr. vaishampayan on systemic therapy followed by cytoreductive nephrectomy in mrcc
-
7:42
dalantercept plus axitinib versus placebo plus axitinib in advanced clear cell renal cell carcinoma